The impact of HIV/AIDS on compliance with antidepressant treatment in major depressive disorder: A prospective study in a South African private healthcare cohort

Table 3 The influence of AD class on AD compliance in MDD patients with/without HIV/AIDS (dispensed items)

MDD patients with HIV/AIDS (dispensed items)
Antidepressant class	n	Acceptable (%)	Unacceptable (%)	P***	Cramer’s V
SSRIs	207	44.93	55.07	<0.0001	0.3450
Diverse antidepressants	148	52.70	37.30
SNRIs	70	58.57	41.43
TCA	41	26.83	73.17
MDD patients without HIV/AIDS (dispensed items)
Antidepressant class	n	Acceptable (%)	Unacceptable (%)	P***	Cramer’s V
SSRIs	9435	51.64	48.36	0.0001	0.0942
SNRIs	5777	56.36	43.64
Diverse antidepressants	5460	48.24	51.76
TCA	2159	43.72	56.28

ISSN: 1742-6405